Kanger's participation at Dortmund International Tobacco Products Exhibition

Sep.15.2022
Kanger's participation at Dortmund International Tobacco Products Exhibition
Shenzhen Kangertech participated in the Dortmund International Tobacco Products and Smoking Accessories Exhibition, showcasing their e-cigarette products.

The Germany Dortmund International Tobacco Products and Accessories Exhibition, also known as the Dortmund Tobacco Exhibition, officially opened for three days from September 15th to 17th after a two-year hiatus. Despite the difficulties of travel and being far away across the ocean, Shenzhen Kang Er Technology Co., Ltd. persevered and participated in the exhibition as planned. Kang Er's booth was located in Hall 1, booth number A28 (1.A28).


在本次展会中展出了康尔所参展的产品。


Kang'er, as one of the earliest electronic cigarette companies to venture into the international market, primarily exports its products and has gained a foothold in the European electronic cigarette market. Its participation in this exhibition signifies a deeper meaning for the company's market expansion, product development, and new product showcase.


Customers experience products at Dortmund exhibition.


According to reports, Shenzhen Kang'er Technology Co., Ltd. was established on July 19, 2007, and is a high-tech enterprise specializing in the research and development, production, and sales of electronic atomization equipment. The company has two independent industrial parks in Dongguan and Shenzhen, with a total area of ​​nearly 50,000 square meters.


Kang Er Disposable E-Cigarette Series


For the past 15 years, this company has focused on developing and expanding overseas, resulting in partnerships covering 45 countries and regions across North America, Europe, Latin America, the Middle East, and Southeast Asia, serving a total of 2.5 billion users worldwide. Throughout the years, the company has been committed to promoting compliant development in the e-cigarette industry and making significant contributions to the standardization of products and the industry.


The customer inquired at the Kornell booth.


At the exhibition, Conr brought its new products and provided explanations to the on-site audience and businesses. It is understood that Conr's electronic cigarette products have been popular with consumers in the European market for many years. Since 2016, Conr has passed the Tobacco Product Directive (TPD) certification in countries such as the UK, Germany, Italy, and Greece.


Kang Er electronic cigarette product line.


According to Zhu Wenxiang, the head of the company, Kangertech participated in the trade show to stay abreast of the latest trends in the rapidly evolving electronic cigarette industry. Despite Kangertech's years of experience and advanced research and development technology, the company recognizes that competition is fierce and wants to continue to improve. The trade show in Europe offered an opportunity for Kangertech to expand its global reach and grow its brand.


To read the latest news and updates on the Dortmund Tobacco Exhibition in Germany, please click on the link below.


1. This article is intended solely for industry professionals to exchange ideas and insights, and does not endorse or recommend any specific brands or products. 2. Smoking is harmful to one's health. Minors are prohibited from reading this article.


This article is an original piece from Shenzhen 2FIRSTS Technology Co., Ltd. The copyright and license to use belong to the company, and no individual or organization is allowed to copy, reproduce, or use the content in any way without authorization. The company reserves the right to pursue legal action against any infringement.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

UK Vape Maker Riot Enters Clacton By-Election to Fight Government 'White Packaging' Proposals
UK Vape Maker Riot Enters Clacton By-Election to Fight Government 'White Packaging' Proposals
British e-liquid manufacturer Riot Labs has introduced a fictional “candidate” called Riot Man around the Clacton parliamentary by-election, seeking to mobilize consumers and retailers against parts of the UK government’s proposed restrictions on vape packaging, device appearance and retail displays. Riot Man is not listed as an official candidate.
Aug.12
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives said on September 23 that it has joined the interagency Trade Fraud Task Force to strengthen enforcement against illegal, misdeclared and smuggled vape and tobacco products. ATF will bring its authority under the Prevent All Cigarette Trafficking Act into the task force, including registration, reporting, shipping and record-inspection requirements covering interstate sales of electronic nicotine delivery systems. ATF said the move will strengthen its ability to trace illicit products from U.S. points of entry through domestic trafficking and distribution networks.
News
Sep.28 by 2Firsts Perspectives
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
According to recent LinkedIn posts from people at VAPORESSO, SMOORE and a German distribution partner, vape brand DOJO will begin rolling out a new global brand identity on September 1, 2026, led by a redesigned handwritten logo. The new visual system will be gradually applied across product packaging, marketing materials and digital assets over the following months. Fabio Corsaro, Head of Marketing and Purchasing at MG Wesel GmbH, said the rebrand was related to trademark issues, but that explanation has not been publicly confirmed by DOJO, VAPORESSO or SMOORE. DOJO is currently promoting its Blast X product in Germany.
Aug.31
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06